Literature DB >> 28161309

Oxytocin differentially alters resting state functional connectivity between amygdala subregions and emotional control networks: Inverse correlation with depressive traits.

Monika Eckstein1, Sebastian Markett2, Keith M Kendrick3, Beate Ditzen1, Fang Liu4, Rene Hurlemann5, Benjamin Becker6.   

Abstract

The hypothalamic neuropeptide oxytocin (OT) has received increasing attention for its role in modulating social-emotional processes across species. Previous studies on using intranasal-OT in humans point to a crucial engagement of the amygdala in the observed neuromodulatory effects of OT under task and rest conditions. However, the amygdala is not a single homogenous structure, but rather a set of structurally and functionally heterogeneous nuclei that show distinct patterns of connectivity with limbic and frontal emotion-processing regions. To determine potential differential effects of OT on functional connectivity of the amygdala subregions, 79 male participants underwent resting-state fMRI following randomized intranasal-OT or placebo administration. In line with previous studies OT increased the connectivity of the total amygdala with dorso-medial prefrontal regions engaged in emotion regulation. In addition, OT enhanced coupling of the total amygdala with cerebellar regions. Importantly, OT differentially altered the connectivity of amygdala subregions with distinct up-stream cortical nodes, particularly prefrontal/parietal, and cerebellar down-stream regions. OT-induced increased connectivity with cerebellar regions were largely driven by effects on the centromedial and basolateral subregions, whereas increased connectivity with prefrontal regions were largely mediated by right superficial and basolateral subregions. OT decreased connectivity of the centromedial subregions with core hubs of the emotional face processing network in temporal, occipital and parietal regions. Preliminary findings suggest that effects on the superficial amygdala-prefrontal pathway were inversely associated with levels of subclinical depression, possibly indicating that OT modulation may be blunted in the context of increased pathological load. Together, the present findings suggest a subregional-specific modulatory role of OT on amygdala-centered emotion processing networks in humans.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Basolateral amygdala; Centromedial amygdala; Emotion; Oxytocin; Superficial amygdala

Mesh:

Substances:

Year:  2017        PMID: 28161309     DOI: 10.1016/j.neuroimage.2017.01.078

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  18 in total

1.  Peripheral oxytocin and vasopressin modulates regional brain activity differently in men and women with schizophrenia.

Authors:  Leah H Rubin; Siyi Li; Li Yao; Sarah K Keedy; James L Reilly; Scot K Hill; Jeffrey R Bishop; C Sue Carter; Hossein Pournajafi-Nazarloo; Lauren L Drogos; Elliot Gershon; Godfrey D Pearlson; Carol A Tamminga; Brett A Clementz; Matcheri S Keshavan; Su Lui; John A Sweeney
Journal:  Schizophr Res       Date:  2018-07-06       Impact factor: 4.939

Review 2.  Sex differences in fear extinction.

Authors:  E R Velasco; A Florido; M R Milad; R Andero
Journal:  Neurosci Biobehav Rev       Date:  2019-05-23       Impact factor: 8.989

3.  Oxytocin Enhances an Amygdala Circuit Associated With Negative Symptoms in Schizophrenia: A Single-Dose, Placebo-Controlled, Crossover, Randomized Control Trial.

Authors:  Samantha V Abram; Lize De Coster; Brian J Roach; Bryon A Mueller; Theo G M van Erp; Vince D Calhoun; Adrian Preda; Kelvin O Lim; Jessica A Turner; Judith M Ford; Daniel H Mathalon; Joshua D Woolley
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

4.  Effect of Intranasal Oxytocin on Resting-state Effective Connectivity in Schizophrenia.

Authors:  Vittal Korann; Arpitha Jacob; Bonian Lu; Priyanka Devi; Umesh Thonse; Bhargavi Nagendra; Dona Maria Chacko; Avyarthana Dey; Anantha Padmanabha; Venkataram Shivakumar; Rose Dawn Bharath; Vijay Kumar; Shivarama Varambally; Ganesan Venkatasubramanian; Gopikrishna Deshpande; Naren P Rao
Journal:  Schizophr Bull       Date:  2022-09-01       Impact factor: 7.348

5.  Intranasal oxytocin decreases fear generalization in males, but does not modulate discrimination threshold.

Authors:  Haoran Dou; Liye Zou; Benjamin Becker; Yi Lei
Journal:  Psychopharmacology (Berl)       Date:  2020-11-25       Impact factor: 4.530

6.  Oxytocin increases eye-gaze towards novel social and non-social stimuli.

Authors:  Monika Eckstein; Vera Bamert; Shannon Stephens; Kim Wallen; Larry J Young; Ulrike Ehlert; Beate Ditzen
Journal:  Soc Neurosci       Date:  2018-11-04       Impact factor: 2.083

7.  Oxytocin induces long-lasting adaptations within amygdala circuitry in autism: a treatment-mechanism study with randomized placebo-controlled design.

Authors:  Kaat Alaerts; Sylvie Bernaerts; Jellina Prinsen; Claudia Dillen; Jean Steyaert; Nicole Wenderoth
Journal:  Neuropsychopharmacology       Date:  2020-03-11       Impact factor: 8.294

8.  Intranasal insulin enhances brain functional connectivity mediating the relationship between adiposity and subjective feeling of hunger.

Authors:  Stephanie Kullmann; Martin Heni; Ralf Veit; Klaus Scheffler; Jürgen Machann; Hans-Ulrich Häring; Andreas Fritsche; Hubert Preissl
Journal:  Sci Rep       Date:  2017-05-09       Impact factor: 4.379

9.  Surface modification of PGP for a neutrophil-nanoparticle co-vehicle to enhance the anti-depressant effect of baicalein.

Authors:  Baoyu Chen; Man Luo; Jianming Liang; Chun Zhang; Caifang Gao; Jue Wang; Jianxin Wang; Yongji Li; Desheng Xu; Lina Liu; Ning Zhang; Huijun Chen; Jing Qin
Journal:  Acta Pharm Sin B       Date:  2017-12-29       Impact factor: 11.413

10.  Individualized Functional Parcellation of the Human Amygdala Using a Semi-supervised Clustering Method: A 7T Resting State fMRI Study.

Authors:  Xianchang Zhang; Hewei Cheng; Zhentao Zuo; Ke Zhou; Fei Cong; Bo Wang; Yan Zhuo; Lin Chen; Rong Xue; Yong Fan
Journal:  Front Neurosci       Date:  2018-04-26       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.